Valuation: IRIDEX Corporation

Market Cap 10.98M 9.63M 9.1M 8.29M 15.52M 1.05B 15.63M 109M 42.17M 538M 41.22M 40.33M 1.73B P/E 2026 *
-5.21x
P/E 2027 * -
Enterprise Value 10.98M 9.63M 9.1M 8.29M 15.52M 1.05B 15.63M 109M 42.17M 538M 41.22M 40.33M 1.73B EV / Sales 2026 *
0.21x
EV / Sales 2027 * 0.2x
Free-Float
61.09%
Yield 2026 *
-
Yield 2027 * -
1 day-0.79%
1 week-6.72%
Current month-13.63%
1 month-12.71%
3 months-47.03%
6 months-52.83%
Current year-45.18%
1 week 0.62
Extreme 0.6202
0.67
1 month 0.61
Extreme 0.607
0.74
Current year 0.61
Extreme 0.607
1.65
1 year 0.61
Extreme 0.607
1.65
3 years 0.61
Extreme 0.607
3.65
5 years 0.61
Extreme 0.607
9.46
10 years 0.61
Extreme 0.607
16.39
Manager TitleAgeSince
Chief Executive Officer 54 30/09/2024
Director of Finance/CFO 68 17/12/2018
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 23/06/2020
Director/Board Member 54 31/08/2018
Director/Board Member 66 16/03/2022
Date Insider Type Main position Quantity % Market Cap. Importance
16/09/26 Buy

Chief Financial Officer

7,900 0.0450%
14/09/26 Buy

Chief Financial Officer

2,354 0.0134%
10/09/26 Buy

Chief Financial Officer

5,100 0.0290%
Change 5-day change 1-year change 3-year change Capi.($)
-0.79%-6.72%-43.69%-68.91% 11.07M
-0.50%+3.62%+46.99%+33.49% 251B
+0.32%+5.99%+23.71%-10.93% 157B
+1.42%+3.01%-7.52%+38.17% 141B
-1.70%+1.34%-55.25%-18.36% 64.75B
+0.65%-2.23%+14.64%+24.23% 49.41B
+1.56%+0.05%-15.70%-20.02% 47.09B
-0.03%+10.43%+41.76%+54.36% 48.73B
+0.75%+2.82%+50.64%+60.00% 42.28B
-1.42%+12.68%+192.87%+105.46% 41.36B
Average +0.03%+3.13%+24.85%+19.75% 84.29B
Weighted average by Cap. +0.11%+4.19%+27.30%+24.53%

Financials

2026 *2027 *
Net sales 52.52M 46.09M 43.53M 39.67M 74.25M 5.03B 74.78M 521M 202M 2.57B 197M 193M 8.27B 55.98M 49.12M 46.39M 42.28M 79.14M 5.37B 79.71M 555M 215M 2.74B 210M 206M 8.81B
Net income -2.09M -1.83M -1.73M -1.58M -2.95M -200M -2.97M -20.69M -8.01M -102M -7.83M -7.66M -328M 1K 877.5 828.76 755.26 1.41K 95.84K 1.42K 9.92K 3.84K 48.96K 3.75K 3.67K 157K
Net Debt - -
Logo IRIDEX Corporation
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Employees
93
Date Price Change Volume
25/09/26 US$0.6250 -0.79% 27,842
24/09/26 US$0.6300 -0.63% 34,844
23/09/26 US$0.6340 -0.24% 17,537
22/09/26 US$0.6355 -1.17% 12,075
21/09/26 US$0.6430 -4.03% 46,131
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.6250USD
Average target price
2.750USD
Spread / Average Target
+340.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRIX Stock